West Chester, PA, United States of America

Ruishan Chow

This inventor holds 4 USPTO granted patents and 3 EPO patents. Top assignee: Johnson Matthey Public Limited Company. Active years: 2019-2023.


% Patents Active = 75.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Ruishan Chow: Innovator in Palladium Complexes

Introduction

Ruishan Chow is a notable inventor based in West Chester, PA (US). He has made significant contributions to the field of chemistry, particularly in the development of palladium complexes. With a total of 4 patents to his name, Chow's work has implications in various chemical reactions.

Latest Patents

Chow's latest patents include innovative advancements in palladium(II) complexes. One of his inventions provides a palladium(II) complex of a specific formula, which is detailed in the specification. This invention also outlines a process for preparing the complex and its applications in carbon-carbon and carbon-heteroatom coupling reactions. Another patent focuses on the synthesis of allyl phosphine complexes of palladium, again detailing a palladium(II) complex of a specific formula. This patent similarly describes the preparation process and its utility in various coupling reactions.

Career Highlights

Ruishan Chow is currently associated with Johnson Matthey Public Limited Company, where he continues to innovate in the field of chemistry. His work has garnered attention for its practical applications in chemical synthesis and catalysis.

Collaborations

Chow has collaborated with esteemed colleagues such as Thomas John Colacot and Andrew Jon DeAngelis, contributing to a rich environment of innovation and research.

Conclusion

Ruishan Chow's contributions to the field of palladium complexes highlight his role as a significant inventor. His patents reflect a commitment to advancing chemical processes and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…